z-logo
Premium
Transplant center support for infectious diseases
Author(s) -
Schaenman Joanna M.,
Kumar Deepali,
Kotton Camille N.,
DanzigerIsakov Lara,
Morris Michele I.
Publication year - 2017
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.12746
Subject(s) - medicine , subspecialty , center of excellence , transplantation , excellence , family medicine , organ transplantation , intensive care medicine , surgery , political science , law
Background Transplant Infectious Diseases ( TID ) is a rapidly growing subspecialty, which has contributed significantly to improving patient outcomes after transplantation. Obtaining institutional support to implement programs that promote excellence in patient care remains a challenge for many non‐surgical transplant‐related specialties. Method We surveyed the membership of the American Society of Transplantation Infectious Diseases Community of Practice to assess characteristics of individual transplant programs and delineate current patterns of institutional support of TID , with a goal of facilitating the exchange of innovative funding ideas between transplant programs. Results Of 53 questionnaires returned, 36 programs reported the existence of a dedicated TID service for adults. Of these, the ratio of dedicated TID providers to the number of solid organ transplant patients transplanted annually ranged from 15:1 to 259:1. A total of 21% of responding programs indicated that they received no support from their institution. Respondents from larger programs were more likely to receive some type of programmatic support. Conclusion Given that the presence of expert TID input into patient care can improve outcomes through direct patient management and transplant team education, we suggest that continued support of the unbillable time contributed by TID practitioners is a critical part of ensuring excellent outcomes after transplantation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here